U.S. Hematology Diagnostics Market To Witness Rapid Development
U.S. Hematology Diagnostics Market Summary The U.S. hematology diagnostics market size was estimated at USD 2.12 billion in 2023 and is projected to grow at a CAGR of 5.3% from 2024 to 2030. This growth is primarily attributed to the rising prevalence of hematological disorders, which are becoming more common due to aging populations and lifestyle-related factors such as sedentary habits, poor diet, and increasing incidences of chronic diseases. These factors have led to greater reliance on diagnostic testing to ensure timely detection and management of such conditions. Moreover, the integration of advanced diagnostic technologies, including flow cytometry, polymerase chain reaction (PCR), and next-generation sequencing (NGS), has significantly improved the accuracy, sensitivity, and efficiency of diagnostic outcomes, driving adoption across healthcare settings. With the elderly population more vulnerable to hematological disorders, there is a growing demand for timel...